WideTrial is a tech-enabled service company specializing in Expanded Access Programs. Expanded Access Programs (EAPs) are a sub-type of clinical trials that are intended first for treatment purposes and secondarily for research purposes. Conducting a well-designed, data-generating EAP can reward an IND holder with vast amounts of real world data, but it also requires deep subject matter expertise, which WideTrial has. The company provides complete CRO-services on its platform of participating treatment centers.